Vassy William Matthew, Beckett Andrew, Dennis Bradley, Duchesne Juan, Kundi Rishi, Nguyen Jonathan, Spalding M Chance, Moore Ernest E
Northeast Georgia Medical Center, Gainesville, Georgia.
St. Michael's Hospital, Toronto, Ontario, Canada.
Shock. 2025 Jan 1;63(1):33-35. doi: 10.1097/SHK.0000000000002500.
Background: Noncompressible torso hemorrhage remains a leading cause of potentially preventable deaths. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as an adjunct temporizing hemorrhage control. The complete occlusion strategy with the ER-REBOA catheter can cause distal ischemia when used for longer than 30 min. To specifically address this limitation, the pREBOA-PRO catheter was developed. The objective of the current study is to investigate the impact of longer, partial occlusion times provided by pREBOA-PRO on acute kidney injury and mortality. Methods: This is a retrospective analysis of the Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry as of August 2023. Patients in the pREBOA-PRO group (n = 110) receiving partial occlusion in Zone 1 were contrasted to patients in the ER-REBOA group (n = 752) treated with complete occlusion in Zone 1. Between-group comparisons included demographics, clinical presentation, aortic occlusion strategy, clinical complications, and mortality. Results: Demographics, clinical presentation, and mortality were indistinguishable between groups, except for age which was higher in the ER-REBOA group (44 vs. 38, P < 0.002). The partial aortic occlusion strategy was employed more often in the pREBOA-PRO group (87% vs. 33%, P < 0.05) and for longer periods (59 min vs. 50 min, P < 0.003). In contrast, AKI occurred less frequently in the pREBOA-PRO group (19% vs. 33%, P < 0.05). Conclusions: The more frequently partial and longer occlusion times in Zone 1 with the use of pREBOA-PRO resulted in lower AKI incidence suggesting that this newer device is a safer extended bridge to hemorrhage control.
不可压缩性躯干出血仍然是潜在可预防死亡的主要原因。复苏性血管内主动脉球囊阻断术(REBOA)已成为一种辅助的临时出血控制方法。当使用ER-REBOA导管进行完全阻断策略超过30分钟时,可导致远端缺血。为了专门解决这一局限性,研发了pREBOA-PRO导管。本研究的目的是调查pREBOA-PRO提供的更长时间的部分阻断对急性肾损伤和死亡率的影响。方法:这是一项对截至2023年8月的创伤和急性护理手术复苏主动脉阻断登记册的回顾性分析。将在1区接受部分阻断的pREBOA-PRO组患者(n = 110)与在1区接受完全阻断治疗的ER-REBOA组患者(n = 752)进行对比。组间比较包括人口统计学、临床表现、主动脉阻断策略、临床并发症和死亡率。结果:除年龄外,两组间的人口统计学、临床表现和死亡率无明显差异,ER-REBOA组年龄更高(44岁对38岁,P < 0.002)。pREBOA-PRO组更常采用部分主动脉阻断策略(87%对33%,P < 0.05),且持续时间更长(59分钟对50分钟,P < 0.003)。相比之下,pREBOA-PRO组急性肾损伤的发生率较低(19%对33%,P < 0.05)。结论:使用pREBOA-PRO在1区更频繁地进行部分阻断且阻断时间更长,导致急性肾损伤发生率降低,这表明这种新型装置是一种更安全的延长出血控制桥梁。